Login
$PTGX
$140.32 +$1.89 (1.37%) Close

Ownership

13F as of Q2 2026 · 64.7M shares outstanding

Who owns PTGX?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 66.6%
BlackRock, Inc. 15.9% · Farallon Capital Management, L.L.C. 9.8%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
342
+22 vs last qtr
Net shares bought
−3.0M
by institutions in Q2 2026
New / sold out
62 / 40
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Jupiter Topco LLC NEW +2.1M
  • BlackRock, Inc. +528.5K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −2.9M
  • UBS Group AG −1.8M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$93.1M
24 notices from 12 people
Shares covered
833.1K
1.29% of the company
Arranged in advance
56%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$16.8M$33.6MNovDecJan 2026: $19.3M without a planJanFeb 2026: $3.2M without a planFebMar 2026: $12.1M without a planMarApr 2026: $184.6K without a planAprMay 2026: $8.7M under a 10b5-1 planMay 2026: $5.9M without a planMayJun 2026: $2.0M under a 10b5-1 planJunJulAug 2026: $33.6M under a 10b5-1 planAugSep 2026: $8.3M under a 10b5-1 planSepOct
Largest proposed sellers
  • Dinesh Patel Ceo $55.9M
  • Asif Ali Officer $14.7M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+84.8%
+13.07% a year
Each share's claim on the business
−45.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $161M
over 6 fiscal years
Diluted shares, split-adjusted
33.4M49.5M65.7M2020: 34.4M shares'202021: 46.3M shares'212022: 49.0M shares'222023: 56.8M shares'232024: 65.1M shares'242025: 63.6M shares'25
Buybacks Stock-based comp
$0$23.0M$46.0M2020 buybacks: $02020 stock comp: $7.9M'202021 buybacks: $02021 stock comp: $16.4M'212022 buybacks: $02022 stock comp: $24.2M'222023 buybacks: $02023 stock comp: $29.3M'232024 buybacks: $02024 stock comp: $37.6M'242025 buybacks: $02025 stock comp: $46.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years63% 3–5 years9% 1–3 years16% Under 1 year12%
Quarterly turnover
11.4%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting PTGX on Form 13F
B
BlackRock, Inc.
Shares
10.3M
% of company
15.93%
Change vs last qtr
+528.5K (+5.4%)
Held since
≤2021
FC
Farallon Capital Management, L.L.C.
Shares
6.3M
% of company
9.81%
Change vs last qtr
Unchanged
Held since
≤2021

28 more super investors behind a free account

See every manager holding Protagonist Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting PTGX on Form N-PORT; together they hold 50.2% of the company
Position value
$446M
% of company
5.63%
% of the fund
0.40%
As of
June 30, 2026
VT
Position value
$251M
% of company
3.16%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Protagonist Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
PD
Patel Dinesh V PH D
Insider
Shares
523.0K
% of company
0.81%
Change vs last qtr
—
Held since
—
GS
Gupta Suneel
Insider
Shares
267.4K
% of company
0.41%
Change vs last qtr
—
Held since
—

7 more holders behind a free account

See every insider and 5%+ holder of Protagonist Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support